Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2012, Article ID 132931, 9 pages
http://dx.doi.org/10.1155/2012/132931
Research Article

Phytochemical Activation of Nrf2 Protects Human Coronary Artery Endothelial Cells against an Oxidative Challenge

1Department of Health and Exercise Science, Colorado State University, 220 Moby B Complex 1582, Fort Collins, CO 80523, USA
2Pulmonary Sciences and Critical Care Medicine, University of Colorado, Denver Anschutz Medical Campus Research Building 29th Floor, 12700 E. 19th Avenue, Aurora, CO 80045, USA

Received 22 December 2011; Accepted 16 March 2012

Academic Editor: Adrian Manea

Copyright © 2012 Elise L. Donovan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. F. Walter, R. F. Jacob, B. Jeffers et al., “Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study,” Journal of the American College of Cardiology, vol. 44, no. 10, pp. 1996–2002, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Robertson, “Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes,” Journal of Biological Chemistry, vol. 279, no. 41, pp. 42351–42354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. Rottkamp, A. Nunomura, A. K. Raina, L. M. Sayre, G. Perry, and M. A. Smith, “Oxidative stress, antioxidants, and Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 14, supplement 1, pp. S62–S66, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Harrison, K. K. Griendling, U. Landmesser, B. Hornig, and H. Drexler, “Role of oxidative stress in atherosclerosis,” American Journal of Cardiology, vol. 91, no. 3, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. C. Carr, M. R. McCall, and B. Frei, “Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 7, pp. 1716–1723, 2000. View at Google Scholar · View at Scopus
  6. C. P. Judkins, H. Diep, B. R. S. Broughton et al., “Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE -/- mice,” American Journal of Physiology, Heart and Circulatory Physiology, vol. 298, no. 1, pp. H24–H32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Lee, N. M. Gharavi, H. Honda et al., “A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids,” Free Radical Biology and Medicine, vol. 47, no. 2, pp. 145–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Rouhanizadeh, J. Hwang, R. E. Clempus et al., “Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase,” Free Radical Biology and Medicine, vol. 39, no. 11, pp. 1512–1522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Landmesser, R. Merten, S. Spiekermann, K. Büttner, H. Drexler, and B. Hornig, “Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation,” Circulation, vol. 101, no. 19, pp. 2264–2270, 2000. View at Google Scholar · View at Scopus
  10. D. Sorescu, D. Weiss, B. Lassègue et al., “Superoxide production and expression of Nox family proteins in human atherosclerosis,” Circulation, vol. 105, no. 12, pp. 1429–1435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Vendrov, Z. S. Hakim, N. R. Madamanchi, M. Rojas, C. Madamanchi, and M. S. Runge, “Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2714–2721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis,” Journal of the American Medical Association, vol. 297, no. 8, pp. 842–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. I. D. Podmore, H. R. Griffiths, K. E. Herbert, N. Mistry, P. Mistry, and J. Lunec, “Vitamin C exhibits pro-oxidant properties,” Nature, vol. 392, no. 6676, p. 559, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Clarke and J. Armitage, “Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials,” Cardiovascular Drugs and Therapy, vol. 16, no. 5, pp. 411–415, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Nelson, S. K. Bose, G. K. Grunwald, P. Myhill, and J. M. McCord, “The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy,” Free Radical Biology and Medicine, vol. 40, no. 2, pp. 341–347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Velmurugan, J. Alam, J. M. McCord, and S. Pugazhenthi, “Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim,” Free Radical Biology and Medicine, vol. 46, no. 3, pp. 430–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Giudice, C. Arra, and M. C. Turco, “Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents,” Methods in Molecular Biology, vol. 647, pp. 37–74, 2010. View at Google Scholar · View at Scopus
  18. V. V. Lyakhovich, V. A. Vavilin, N. K. Zenkov, and E. B. Menshchikova, “Active defense under oxidative stress. The antioxidant responsive element,” Biochemistry. Biokhimiia, vol. 71, no. 9, pp. 962–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. J. Surh, J. K. Kundu, and H. K. Na, “Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals,” Planta Medica, vol. 74, no. 13, pp. 1526–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. He, R. C. M. Siow, D. Sugden, L. Gao, X. Cheng, and G. E. Mann, “Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 4, pp. 277–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Kadl, A. K. Meher, P. R. Sharma et al., “Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2,” Circulation Research, vol. 107, no. 6, pp. 737–746, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Warabi, W. Takabe, T. Minami et al., “Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species,” Free Radical Biology and Medicine, vol. 42, no. 2, pp. 260–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. H. K. Jyrkkänen, E. Kansanen, M. Inkala et al., “Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo,” Circulation Research, vol. 103, no. 1, pp. e1–e9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Ungvari, L. Bailey-Downs, T. Gautam et al., “Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 300, no. 4, pp. H1133–H1140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Jiang, X. Tian, Y. Guo, W. Duan, H. Bu, and C. Li, “Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity,” Biological and Pharmaceutical Bulletin, vol. 34, pp. 1194–1197, 2011. View at Google Scholar
  26. S. Liu, W. Hou, P. Yao et al., “Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage,” Toxicol in Vitro, vol. 26, no. 1, pp. 74–80, 2012. View at Google Scholar
  27. B. Joddar, R. K. Reen, M. S. Firstenberg et al., “Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway,” Free Radical Biology and Medicine, vol. 50, no. 6, pp. 700–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Taillé, J. El-Benna, S. Lanone et al., “Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability,” Journal of Biological Chemistry, vol. 279, no. 27, pp. 28681–28688, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. E. Silver, S. D. Beske, D. D. Christou et al., “Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47phox expression and evidence of endothelial oxidative stress,” Circulation, vol. 115, no. 5, pp. 627–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. R. Brandes and K. Schröder, “Differential vascular functions of Nox family NADPH oxidases,” Current Opinion in Lipidology, vol. 19, no. 5, pp. 513–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. C. E. Romanoski, N. Che, F. Yin et al., “Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1,” Circulation Research, vol. 109, pp. e27–e41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Liu, X. Gu, D. Robbins et al., “Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model,” PloS one, vol. 4, no. 4, article e5284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Maher and M. Yamamoto, “The rise of antioxidant signaling-The evolution and hormetic actions of Nrf2,” Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 4–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. P. Hussain, P. Amstad, P. He et al., “p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis,” Cancer Research, vol. 64, no. 7, pp. 2350–2356, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. P. T. Pfluger, D. Herranz, S. Velasco-Miguel, M. Serrano, and M. H. Tschöp, “Sirt1 protects against high-fat diet-induced metabolic damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 28, pp. 9793–9798, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Xu, Y. Sun, Y. Chen et al., “Endothelial cell apoptosis is reponsible for the formation of coronary thrombotic atherosclerotic plaques,” Tohoku Journal of Experimental Medicine, vol. 218, no. 1, pp. 25–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Hulsmans and P. Holvoet, “The vicious circle between oxidative stress and inflammation in atherosclerosis,” Journal of Cellular and Molecular Medicine, vol. 14, no. 1-2, pp. 70–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. S. Frey, M. Ushio-Fukai, and A. B. Malik, “NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology,” Antioxidants and Redox Signaling, vol. 11, no. 4, pp. 791–810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. V. E. A. Stoneman and M. R. Bennett, “Role of apoptosis in atherosclerosis and its therapeutic implications,” Clinical Science, vol. 107, no. 4, pp. 343–354, 2004. View at Publisher · View at Google Scholar · View at Scopus